Home Precisio Biotix

Precisio Biotix

In operation
-
Precision Targeted Antibacterial Biopharmaceuticals Developer

Basic Information

Precisio is a global biotechnology company focused on the development and commercialization of precision-targeted antibacterial biologics, dedicated to developing novel, low-cost precision bio-antimicrobials, initially targeting skin and lung infections. Precisio is a platform-plus-product company (Rx, consumer). The management team has successfully exited multiple times in the past. Precisio is currently seeking to add strategic and impact investors.
Precisio Biotix Therapeutics, Inc.
--
15~50 people
January 01, 2013
shencj@precisiobiotix.com